Saturday, November 14, 2026

Digital banks using AI credit models grow 7x faster but face 10%+ delinquency spikes during regulatory shifts

Nu Holdings deployed its nuFormer AI underwriting model in 2025 and launched 100+ products, while Inter & Co added 7 million clients in its best year ever. When Brazil changed FGTS regulations in November 2025, Nu's portfolio growth dropped from 13-14% to 10%, exposing concentrated model risk in AI-driven lending.

From our archive, published before source-traceability. How we work

Digital banks using AI credit models grow 7x faster but face 10%+ delinquency spikes during regulatory shifts
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Nu Holdings' nuFormer AI model went live in 2025, enabling the digital bank to launch over 100 products and features in a single year. Inter & Co welcomed 7 million new clients in 2025, its strongest annual performance, with newer customer cohorts transacting faster than older ones onboarded through traditional methods.

The speed advantage disappeared when external conditions shifted. Brazil's November 2025 FGTS regulation changes caused Nu's portfolio growth to slow from an expected 13-14% to roughly 10% within weeks. Inter projects its cost of risk will hit 5.5-6% in 2026, with private payroll loan delinquency climbing above 10%.

AI-native underwriting creates concentrated model risk because millions of customers are approved using identical algorithms trained on similar data. Traditional banks spread risk across multiple human underwriters making independent decisions with different risk tolerances and local knowledge.

Nu typically sees seasonal increases in 15-90 day non-performing loans during Q1, indicating vulnerability to predictable external shocks. The FGTS regulatory change represented an unpredictable shock that AI models trained on historical data couldn't anticipate.

Digital banks achieve faster customer acquisition because AI models process applications in seconds rather than days, require minimal documentation, and operate 24/7 without human review. Inter's 7 million new clients in one year would require thousands of loan officers using traditional methods.

The tradeoff manifests during downturns. When economic conditions or regulations change, AI models continue approving customers using pre-crisis patterns until delinquency data accumulates and triggers model retraining. Traditional underwriters adjust risk appetites immediately based on news and local economic signals.

Emerging markets amplify this dynamic because regulatory frameworks evolve rapidly and economic volatility exceeds developed markets. Brazil's consumer credit regulations changed three times in 2025, each time creating lag periods where AI models operated on outdated assumptions.

The financial impact is measurable: Nu's 3-4 percentage point growth slowdown on a multi-billion dollar portfolio represents hundreds of millions in reduced revenue. Inter's projected 10%+ delinquency rate on payroll loans will require significant loan loss provisions.

Banks now face a fundamental choice: accept slower growth with diversified underwriting risk, or chase AI-driven acquisition knowing regulatory changes and economic shocks will cause sharp delinquency spikes.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com